A2a Pharmaceuticals, Inc.'s Net Worth
A2a Pharmaceuticals, Inc.'s net worth is estimated to be at least $13,780,695.94 as of 09/17/2024. CoreStreet's estimation of A2a Pharmaceuticals, Inc.'s net worth is based on their sale of stock and current holding of stock.
A2a Pharmaceuticals, Inc. is Major Shareholder at Biomea Fusion Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 75,000 units of BMEA stock on 05/31/2023. Their biggest sale was on 04/20/2023 when they sold 200,000 units of Biomea Fusion Inc stock for $5,824,000.00. They typically trade 2 times per year.
Total value of insider buys:
- $379,851.68
Total value of insider sells:
- $13,400,844.26
Most recent insider trade:
- May 31, 2023
A2a Pharmaceuticals, Inc.'s Insider Trading History
| Biomea Fusion Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 31, 2023 | Major Shareholder | 75,000 | $33.81 | Sell | $2,535,750.00 |
May 12, 2023 | Major Shareholder | 25,000 | $33.84 | Sell | $846,000.00 |
May 8, 2023 | Major Shareholder | 100,000 | $33.99 | Sell | $3,399,000.00 |
April 20, 2023 | Major Shareholder | 200,000 | $29.12 | Sell | $5,824,000.00 |
July 21, 2022 | Major Shareholder | 34,658 | $11.21 | Sell | $388,516.18 |
June 24, 2022 | Major Shareholder | 34,658 | $11.76 | Sell | $407,578.08 |
Sept. 17, 2021 | Major Shareholder | 34,658 | $10.96 | Buy | $379,851.68 |